Both central and peripheral OT treatments induce body weight loss in obese animal models with impaired leptin signaling, in diet-induced obesity rhesus monkeys and in obese humans [56]. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.